Page 75 - Go4it
P. 75

1.1 (15.3)
-, PedsQLTM4.0 and BES
.1; 1.7)
tervention group and control
and 18 months follow-u 1.8 (0.7) 2.1 (0.6)
2; 0.3)
0.1 (-0.1; 0.4)
1.6 (0.7)
1.7 (0.7)
0.2 (0.0; 0.5)
1.8 (0.8)
2.1 (0.7)
0; 0.5)
0.3 (0.0; 0.6)
78.5 (11.2) 83.1 (11.8) 76.9 (12.0) 77.9 (15.3) 81.8 (14.0) 71.1 (15.0)
Intervention g
onths .2; 02)3
18 months
m
0.9 (10.1) 82.6 (10.9)
vention group between                                                                 y unstandardised regression
Baseline
6 months
% CI)
B (95% CI)
Quality of life
 , PedsQLTM4.0 and BES mean (SD) scores and between group difference between the intervention group and control and 18 months follow-up
s
oup 18
82 8
81 86
           2 mo
.2 ( 5.1 (
.7 ( .7 (
     nth
10.4 9.9)
12.0 11.8
          s
)
) )
     Base
78.3 ( 81.5 (
75.7 ( 76.4 (
    line
11.1 10.0
10.7 13.2
        Co
) )
) )
       ntr 6m
82. 83.
77.9 78.6
     ol gr ont
5 (9. 9 (8.
(10 (11
     oup hs
9) 3)
.0) .9)
     2 18
80 83
77 79
   mo
.4 ( .5 (
.2 ( .8 (
      nth
11.6 10.2
10.5 11.4
       s
) )
) )
     6 B(
-2.0 -1.5
-0.1 3.6
     mo 95
(-6 (-5
(-3 (-1.
 80 76 87
76 me
ps
roup
     poss 8
o4
erve
1
8 34-
2
1
2
.0 (
.1 (
.3 (
.6 ( an (
.2 (0
 2
.7 (0
8 mo
.3 (0
ible 2.2 ( (best
ntion
5.1 ( 35
12.8
17.9
12.4
16.2 SD)
.7)
       .7)
nth
 .8)
scor 10.4 pos
 gro
9.9 and
) ) ) )
scor
s
       e) t )
sibl )up
in t
75.4 (
74.5 (
78.8 (
73.0 ( es an
1.9 (
 1.7 (
Base
1.9 (
o 100 78.3 ( e scor
and 3
81.5 ( he co
11.2
15.8
16.1
15.4 d be
0.8)
    0.6)
line
1.0)
(be 11.
e),
3-34
10. ntro
)
)
)
) twe
Co
st p 1) with
       in t
0)
l gr
77.8
76.1
82.8
75.5 en g
    2.1
ntr
1.8
6
1.9
ossib 82. high
he c
83. oup
(10
(12
(14
(15 rou
    (0.
ol g
(0.
ont
(0.
le s 5 (9 er s
ont
9 (8 fro
.2)
.0)
.0)
.3) p dif
    7)
rou
7)
hs
7)
core .9) core
rol g
.3) m2
76 76 81 71
fere
p2 2
    1
2
) wi 8 s re
rou
8 3-2
1
.4 (
.1 (
.3 (
.7 ( nce
.2 (
 .8 (
8m
.0 (
th h 0.4 ( pre
p. Af
3.53( 8.
11.6 16.4 13.9 14.4
bet
0.7)
       0.7)
ont
0.6)
ighe
11. senti
ter
10. As
)
)
)
) wee
hs
    r sc 6)
ng
the
2) indi
-1.0
1.5
-0.5
-3.2 n th
0.0
    0.0
B
0.2
ores -2. a be
18
-1. cate
(-4
(-4.
(-5
(-8 e in
     (-0.
6m
(-0
(95
(0.
  rep 0 (-
tter
mon
5 (- db
CI),
8 8 8 7 8 7
    adju
1.7 ( 6.7 ( 0.0 ( 6.1 ( 7.3 ( 6.6 (
2.2 ( 1.7 (
 sted
12.0 11.8 12.8 17.9 12.4 16.2
0.7) 0.7)
       for
) ) ) ) ) )
   baseli
75.7 ( 76.4 ( 75.4 ( 74.5 ( 78.8 ( 73.0 (
1.9 ( 1.7 (
 ne v
10. 13. 11. 15. 16. 15.
0.8) 0.6)
  alue
7) 2) 2) 8) 1) 4)
   , ag
77. 78. 77. 76. 82. 75.
2. 1.
  e, s
9(10 6(11 8(10 1(12 8(14 5(15
1 (0. 8 (0.
  ex a
.0) .9) .2) .0) .0) .3)
7) 7)
  nd
7 7 7 7 8 7
  ethn
7.2 ( 9.8 ( 6.4 ( 6.1 ( 1.3 ( 1.7 (
2.2 ( 1.8 (
 icity
10. 11. 11. 16. 13. 14.
0.7) 0.7)
   ,4
5) 4) 6) 4) 9) 4)
  = eff
-0. 3. -1. 1. -0. -3.
0. 0.
  ect
1 (- 6 (-1 0 (- 5 (-4 5 (- 2 (-
0 (-0 0 (-
              pos to 4 terve
34 CI),
 2.3 (
sible (bes ntio
-35 adju
   0.8)
sco t po n gr and
sted
         re) t ssibl oup
in for
 1.9 (
o 100 e scor and 3 the co baseli
   1.0)
(be e),
3-3 ntr ne
        st p with
4 in ol gr
valu
  1.
ossi hig the
oup e, a
    9 (0.
ble her
cont fro
ge,
   7)
scor scor rol
m2 sex
    e) w es r grou
3-2 and
 2.0 (
ith epre p. A 8. 3 eth
    0.6)
high sent fter As
nicit
       er s ing the
indi y, 4
  0.
core a be 18
cat = ef
   2 (0
s re tter mon
ed b fect
 Baseline
8.2 (12.1) 0.9 (10.1)
5.1 (12.2)
6.5 (14.8)
4.7 (12.6)
4.7 (17.2)
8.2 (15.5)
6 months
80.2 (11.2) 82.6 (10.9)
Intervention gr
nths % CI) 3
.6; 2.5) .9; 2.8)
.5; 3.3) 0; 8.2) .6; 2.6) 1; 7.1) .1; 4.1)
18 months B (95% CI)
2.3 (-2.9; 7.4) 1.0 (-4.0; 6.0)
3.8 (-0.2; 7.7) 5.4 (0.3; 10.6)4 3.4 (-0.8; 7.6) 1.8 (-4.8; 8.4)
Quality of life 2.4 (-3.0; 7.8)
7.4 (1.6; 13.2)5
              .0 range from 0 (worst 8.2 (12.1) 80.2 (11.2) (worst possible score) t
resenting a better quality of 6.6; 2.5) 2.23 (-2.9; 7.4)
hs from 44-45 in the int
body esteem, The numbers
fidence intervals (95%
5.9; 2.8) 1.0 (-4.0; 6.0) size d: 0.7, 5 = effect size d:
ths follow-up the numbers of
 5.1 (12.2) 6.5 (14.8) 4.7 (12.6) 4.7 (17.2) 8.2 (15.5) 1.1 (15.3)
1.8 (0.7) 1.6 (0.7) 1.8 (0.8)
78.5 (11.2) 83.1 (11.8) 76.9 (12.0) 77.9 (15.3) 81.8 (14.0) 71.1 (15.0)
2.1 (0.6) 1.7 (0.7) 2.1 (0.7)
3.5; 3.3) .0; 8.2) 4.6; 2.6) .1; 7.1) 5.1; 4.1) 8.1; 1.7)
.2; 0.3) 0.2; 02) .0; 0.5)
3.8 (-0.2; 7.7) 5.4 (0.3; 10.6)4 3.4 (-0.8; 7.6)
1.8 (-4.8; 8.47)5
2.4 (-3.0; 7.8) 7.4 (1.6; 13.2)5
0.1 (-0.1; 0.4) 0.2 (0.0; 0.5) 0.3 (0.0; 0.6)
                4.0 range from 0 (worst 0 (worst possible score) ths from 44-45 in the in rvention group between nfidence intervals (95%
presenting a better quality of body esteem, 2 The numbers ths follow-up the numbers of y unstandardised regression size d: 0.7, 5 = effect size d:
75
-
s
4 7 0
t
8 r
n
7 7 7 7 7 7
e
Table 2: CHQ- CF87 scale -, PedsQLTM4.0 and BES mean (SD) scores and between group difference between the intervention group and control group at baseline, 6 months and 18 months follow-ups
CHQ-C871
Physical summary scale
78.2 (12.1) 80.9 (10.1)
80.2 (11.2) 82.6 (10.9)
82.2 (10.4) 85.1 (9.9)
78.3 (11.1) 81.5 (10.0)
82.5 (9.9) 83.9 (8.3)
80.4 (11.6) 83.5 (10.2)
-2.0 (-6.6; 2.5) -1.5 (-5.9; 2.8)
2.3 (-2.9; 7.4) 1.0 (-4.0; 6.0)
Psychosocial summary scale
PedsQLTM4.01
Total score
Physical health Psychosocial health Emotional functioning Social functioning School functioning BES1
Body appearance Weight satisfaction* Body attribution
75.1 (12.2) 76.5 (14.8) 74.7 (12.6) 74.7 (17.2) 78.2 (15.5) 71.1 (15.3)
78.5 (11.2) 83.1 (11.8) 76.9 (12.0) 77.9 (15.3) 81.8 (14.0) 71.1 (15.0)
81.7 (12.0) 86.7 (11.8) 80.0 (12.8) 76.1 (17.9) 87.3 (12.4) 76.6 (16.2)
75.7 (10.7) 76.4 (13.2) 75.4 (11.2) 74.5 (15.8) 78.8 (16.1) 73.0 (15.4)
77.9(10.0) 78.6(11.9) 77.8(10.2) 76.1(12.0) 82.8(14.0) 75.5(15.3)
77.2 (10.5) 79.8 (11.4) 76.4 (11.6) 76.1 (16.4) 81.3 (13.9) 71.7 (14.4)
-0.1 (-3.5; 3.3) 3.6 (-1.0; 8.2) -1.0 (-4.6; 2.6) 1.5 (-4.1; 7.1) -0.5 (-5.1; 4.1) -3.2 (-8.1; 1.7)
3.8 (-0.2; 7.7) 5.4 (0.3; 10.6)4 3.4 (-0.8; 7.6) 1.8 (-4.8; 8.4) 2.4 (-3.0; 7.8) 7.4 (1.6; 13.2)5
Baseline
6 months
18 months
Baseline
6 months
18 months
1.8 (0.7) 1.6 (0.7) 1.8 (0.8)
2.1 (0.6) 1.7 (0.7) 2.1 (0.7)
2.2 (0.7) 1.7 (0.7) 2.3 (0.8)
1.9 (0.8) 1.7 (0.6) 1.9 (1.0)
2.1 (0.7) 1.8 (0.7) 1.9 (0.7)
2.2 (0.7) 1.8 (0.7) 2.0 (0.6)
0.0 (-0.2; 0.3) 0.0 (-0.2; 02) 0.2 (0.0; 0.5)
0.1 (-0.1; 0.4) 0.2 (0.0; 0.5) 0.3 (0.0; 0.6)
Intervention group2
Control group2
6 months B (95% CI) 3
18 months B (95% CI)
1 CHQ scores and PedsQLTM4.0 range from 0 (worst
life. BES scores range from 0 (worst possible score) to 4 (best possible score), with higher scores representing a better body esteem, 2 The numbers of subjects varied at 6 months from 44-45 in the intervention group and 33-34 in the control group. After the 18 months follow-up the numbers of subjects varied in the intervention group between 34-35 and in the control group from 23-28. 3 As indicated by unstandardised regression coefficients (B) and 95% confidence intervals (95% CI), adjusted for baseline value, age, sex and ethnicity, 4 = effect size d: 0.7, 5 = effect size d: 0.3
possible score) to 100 (best possible score) with higher scores representing a better quality of
Quality of life
75
   73   74   75   76   77